Firefly Neuroscience (AIFF) Equity Average (2011 - 2026)

Firefly Neuroscience's Equity Average history runs 14 years deep, the most recent figure standing at $8.0 million for Q1 2026.

• In Q1 2026, Equity Average rose 234.28% year-over-year to $8.0 million; the TTM figure through Mar 2026 stood at $8.0 million (up 234.28% YoY), while the FY2025 annual figure was $3.6 million, up 330.54% from the prior year.
• Equity Average was $8.0 million for Q1 2026 at Firefly Neuroscience, down from $8.6 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $16.6 million in Q1 2022 to a low of -$2.0 million in Q3 2024.
• Historically, Equity Average has averaged $4.9 million across 5 years, with a median of $2.4 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Equity Average plunged 290.56% in 2024, then surged 4710.0% in 2025.
• A 5-year view of Equity Average shows it stood at $5.2 million in 2022, then plunged by 108.83% to -$459500.0 in 2023, then plunged by 242.76% to -$1.6 million in 2024, then soared by 649.02% to $8.6 million in 2025, then dropped by 7.03% to $8.0 million in 2026.
• The last three Equity Average figures came in at $8.0 million (Q1 2026), $8.6 million (Q4 2025), and $10.9 million (Q3 2025), per Business Quant data.